Formulation and Efficacy of Catalase-Loaded Nanoparticles for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy

Neonatal hypoxic-ischemic encephalopathy is the leading cause of permanent brain injury in term newborns and currently has no cure. Catalase, an antioxidant enzyme, is a promising therapeutic due to its ability to scavenge toxic reactive oxygen species and improve tissue oxygen status. However, upon...

Descripción completa

Detalles Bibliográficos
Autores principales: Joseph, Andrea, Nyambura, Chris W., Bondurant, Danielle, Corry, Kylie, Beebout, Denise, Wood, Thomas R., Pfaendtner, Jim, Nance, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400001/
https://www.ncbi.nlm.nih.gov/pubmed/34452092
http://dx.doi.org/10.3390/pharmaceutics13081131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400001/
https://www.ncbi.nlm.nih.gov/pubmed/34452092
http://dx.doi.org/10.3390/pharmaceutics13081131

Ejemplares similares